Investor desk
Investors should track partnership announcements and pipeline signals from EASD.
← Back to Events
Tier 1 Global Networking: High DIABETES 68 DAYS AWAY
EASD — 2026 — Allianz MiCo - Milan Convention Centre, Milan, Italy
EASD 2026 | EASD Home/ Annual Meeting/ EASD 2026 # EASD Annual Meeting 2026 The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from 28 September to 2 October 2026 at the Allianz MiCo - Milan Convention Centre in Milan, Ita
Presentation data updated Jul 22, 2026, 2:31 AM UTC
Why This Event Matters
EASD 2026 | EASD Home/ Annual Meeting/ EASD 2026 # EASD Annual Meeting 2026 The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from 28 September to 2 October 2026 at the Allianz MiCo - Milan Convention Centre in Milan, Italy.
Industry impact
EASD 2026 | EASD Home/ Annual Meeting/ EASD 2026 # EASD Annual Meeting 2026 The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from 28 September to 2 October 2026 at the Allianz MiCo - Milan Convention Centre in Milan, Italy.
Market implications
Expect signals on pricing, formulary strategy, and partnership economics in EU markets.
Regulatory implications
EMA and national HTA frameworks are frequently debated at industry gatherings.
Investor implications
Investors should track partnership announcements and pipeline signals from EASD.
Competitive implications
Competitive positioning among diabetes players is a core theme — compare with prior editions.
Event Significance
Tier-1 industry catalyst
30 /100 composite
EASD is a targeted diabetes forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.
- Speaker quality 14/20
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
- Company participation 0/20
Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.
- Historical influence 10/20
Some historical catalysts; compare readouts against last cycle.
- Media coverage 6/20
Niche coverage — subscribe for direct abstract alerts.
- Pipeline relevance 0/20
Early science or services-focused — lower near-term PDUFA linkage.
Key Takeaways
Key Themes
diabetesPipeline announcements
Key Markets
Europe
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Timeline & Milestones
- Pre-event intelligence Upcoming
Abstract discovery in progress; monitor Key Data tab.
- Conference opens Sep 28, 2026 Upcoming
Live readouts, late-breakers, and partnership announcements.
- Live coverage window Upcoming
Nova editorial monitors confirmed data releases.
- Conference closes Oct 2, 2026 Upcoming
Post-event recap, competitive takeaways, and trial updates.
BD teams Investors & analysts Regulatory leaders
Executive Summary
C-level briefEASD 2026 | EASD Home/ Annual Meeting/ EASD 2026 # EASD Annual Meeting 2026 The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from 28 September to 2 October 2026 at the Allianz MiCo - Milan Convention Centre in Milan, Italy.
Primary audience: BD teams · Investors & analysts · Regulatory leaders
Analyst Watch
Regulatory affairs
EMA and national HTA frameworks are frequently debated at industry gatherings.
Competitive intelligence
Competitive positioning among diabetes players is a core theme — compare with prior editions.
Competitive Landscape
Company map →Competitive positioning among diabetes players is a core theme — compare with prior editions.
Coverage & Analysis
No coverage articles yet. Check back closer to the event.
Related News & Research
Research hub →Event Intelligence Summary
Standalone summaries for EASD — optimized for research and AI retrieval.
Executive Summary
EASD 2026 | EASD Home/ Annual Meeting/ EASD 2026 # EASD Annual Meeting 2026 The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from 28 September to 2 October 2026 at the Allianz MiCo - Milan Convention Centre in Milan, Italy.
Analyst View
EASD 2026 | EASD Home/ Annual Meeting/ EASD 2026 # EASD Annual Meeting 2026 The 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from 28 September to 2 October 2026 at the Allianz MiCo - Milan Convention Centre in Milan, Italy.
Investor View
Investors should track partnership announcements and pipeline signals from EASD.
BD View
BD teams should prioritize partnership and licensing conversations at EASD.
Key Facts
- Event
- EASD
- Focus
- diabetes
- Region
- Europe
- Location
- Milan, Italy
Ask Nova AI
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Frequently Asked Questions
What is EASD?
EASD is a diabetes industry conference for executives, clinical leaders, and investors.
Who attends EASD?
Typical attendees include pharma executives, BD teams, investors, and regulatory professionals focused on diabetes.
Why is EASD important?
EASD influences partnership timing and policy debates affecting diabetes markets for the next 12–18 months.
Where is EASD held?
EASD is held in Milan, Italy.
What should investors watch at EASD?
Track partnership announcements, pipeline readouts, and management commentary on diabetes catalysts.
What BD opportunities exist at EASD?
BD teams use EASD for licensing, co-development, and vendor selection across diabetes.
How does EASD compare with other pharma conferences?
EASD is a tier-1 global congress for diabetes — compare with peer events in the same vertical.
How do I get NovaPharmaNews coverage of EASD?
Subscribe to event alerts on this page for pre-event briefs, live coverage, and post-event analysis.